Lecture 20 - Recombinant proteins Flashcards

1
Q

Key 5 steps in producing a recombinant protein

A
  1. Isolate gene of interest
  2. Clone into expression plasmid –
  3. Tranform into bacteria for expression or isolation of more DNA for use in another
    expression system
  4. Grow cells expressing protein of interest
  5. Isolate and purify the protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Advantages of prokaryotic systems

A

relatively low cost
high yield
pathogen free

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Disadvantages of prokaryotic systems

A

proteins often partially folded

inability to perform post-translational modifications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Recombinant Insulin production Step 1

A

Reverse transcriptase

cDNA = no introns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Insulin is produced in

A

pancreas as pre-proprotein further processed by Golgi
– won’t happen in bacteria

Solution = express
chain A and B
separately in bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
Insulin Production
Step 1
Step 2/3
Step 4
Step 5
A

Recombinant Insulin production.
Clone gene into expression plasmid(s) and transform bacteria.
Grow bacteria expressing insulin A and B chains.
Extract and purify.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Step 2-3 Clone gene into expression plasmid(s) and transform bacteria

A

lac Z gene
Promoter
Antibiotic resistance gene
Insulin Gene A or B subunit

Transforms in E. Coli host

lac Z / Insulin A or B fusion protein accumulates in cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Protein purification

A

Recombinant insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Step 5. Extract and purify

A

lac Z / insulin fusion proteins

Treat with Cyanogen bromide to cleave A and B chains

Purify mix A and B chains to form functional insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why Make recombinant insulin in mammalian cells?

A

– Protein can be produced as
a pre-pro-protein and processed efficiently

– Will be secreted from cells (easier purification)

– More expensive to produce.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Making recombinant insulin in eukaryotic cells 5 Steps

A
  • Step 1. Isolate cDNA for insulin
  • Step 2. Clone into eukaryotic expression plasmid
  • Step 3. Transform bacteria to produce more plasmid DNA and then transfect eukaryotic cells
  • Step 4. Extract recombinant insulin from cell media
  • Step 5. Purify insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Making recombinant insulin in eukaryotic cells

Step 1.

A

Isolate cDNA for insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Making recombinant insulin in eukaryotic cells

Step 2

A

Clone into eukaryotic expression plasmid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Making recombinant insulin in eukaryotic cells

Step 3

A

Transform bacteria to produce more plasmid DNA and then transfect eukaryotic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Making recombinant insulin in eukaryotic cells

Step 4.

A

Extract recombinant insulin from cell media

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Making recombinant insulin in eukaryotic cells

Step 5.

A

Purify insulin

17
Q

Some proteins are only active when

A

post-translationally modified

18
Q

recombinant human proteins

A

Therapeutic proteins –

19
Q

Glycosylation

A

requires mammalian cells e.g. erythropoietin = EPO

20
Q

EPO as a performance enhancing drug – blood doping effects

A

increase RBCs
increase in oxygenation of muscle

muscle uses oxygen to burn sugar and fats to generate
ATP

ATP required for muscle contraction

21
Q

Why would we want to make recombinant EPO?

A

restore RBC levels

lowered RBC counts.

chronic renal failure decrease in EPO levels, leading to anaemia (decrease
in RBC levels)

cancer treatments (chemotherapy) may lead to anaemia

22
Q

Erythropoietin (EPO) gene cloned in 1980s

A

protein is post-translationally modified (glycosylation)

made in Chinese Hamster Ovary (CHO) cells

23
Q

glycosylation

A

Addition of carbohydrates to asparagine, serine or threonine residues.

important for biological function.

24
Q

Pharming:

A

using whole animals to make recombinant proteins

25
Q

Expression vector for EPO

A

Promoter – for transcription in mammalian cells

Human EPO

Protein purification

26
Q

cells in culture cannot perform all

A

post-translational modifications equally well

e.g. γ carboxylation of glutamate

27
Q

what is a feature of many

proteins involved in blood clotting?

A

γ-carboxylation of certain glutamate residues

28
Q

anti-thrombin (AT)

A

2006 (Europe) 1st recombinant protein transgenic animal was approved as a drug

29
Q

AT deficiency

A

hereditary or acquired

1 / 2000-5000

increase risk of blood clotting

30
Q

deficient individuals receive AT when

A

undergoing surgery or giving birth

31
Q

AT protein expressed in

A

milk of transgenic goats at lactation

AT then purified from other milk proteins

32
Q

milk specific promoter

A

responds to hormonal signals that induce lactation

33
Q

Recombinant DNA technologies are important for

A

production therapeutic proteins

provide a safe means of getting human proteins for clinical use

34
Q

Eukaryotic systems must be used

A

for proteins that require post-translational modification for their activity

35
Q

There are a variety of cell systems available for

A

producing recombinant proteins